News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
636,756 Results
Type
Article (20280)
Company Profile (202)
Press Release (616674)
Multimedia
Podcasts (55)
Webinars (13)
Section
Business (211506)
Career Advice (731)
Deals (31906)
Drug Delivery (50)
Drug Development (64222)
Employer Resources (58)
FDA (13394)
Job Trends (11720)
News (299826)
Policy (23148)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1516)
Accelerated approval (32)
ADA (26)
Adcomms (2)
Allergies (161)
Alliances (47159)
ALS (151)
Alzheimer's disease (1300)
Antibody-drug conjugate (ADC) (417)
Approvals (14112)
Artificial intelligence (719)
ASCO (204)
Autoimmune disease (279)
Automation (61)
Bankruptcy (298)
Best Places to Work (9328)
BIO (51)
Biologics (2)
BIOSECURE Act (7)
Biosimilars (138)
BioSpace Insights (96)
Biotechnology (137)
Bladder cancer (170)
Brain cancer (52)
Breast cancer (635)
Cancer (4970)
Cardiovascular disease (329)
Career advice (620)
Career pathing (13)
CAR-T (315)
CDC (12)
Celiac Disease (1)
Cell therapy (819)
Cervical cancer (46)
Clinical research (57100)
Collaboration (2081)
Commercialization (4)
Company closure (1)
Compensation (1521)
Complete response letters (41)
COVID-19 (1503)
CRISPR (117)
C-suite (1118)
Cystic fibrosis (114)
Data (7226)
Decentralized trials (2)
Denatured (28)
Depression (123)
Dermatology (78)
Diabetes (459)
Diagnostics (6573)
Digital health (67)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (318)
Drug pricing (24)
Drug shortages (7)
Duchenne muscular dystrophy (202)
Earnings (84696)
Editorial (11)
Employer branding (9)
Employer resources (53)
Events (108487)
Executive appointments (1018)
FDA (16995)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (30)
Funding (1577)
Gene editing (243)
Generative AI (54)
Gene therapy (584)
GLP-1 (502)
Government (1833)
Grass and pollen (4)
Guidances (356)
Healthcare (14436)
Hematology (123)
HIV (71)
Huntington's disease (28)
IgA nephropathy (78)
Immunology and inflammation (140)
Immuno-oncology (72)
Indications (196)
Infectious disease (1787)
Inflammatory bowel disease (161)
Inflation Reduction Act (6)
Influenza (126)
Intellectual property (315)
Interviews (84)
IPO (14977)
IRA (10)
Job creations (2752)
Job search strategy (556)
JPM (22)
Kidney cancer (19)
Labor market (27)
Layoffs (177)
Leadership (8)
Legal (6032)
Licensing (9)
Liver cancer (72)
Longevity (30)
Lung cancer (617)
Lymphoma (349)
Machine learning (56)
Management (20)
Manufacturing (978)
Marketing (10)
MASH (141)
Medical device (13704)
Medtech (13940)
Mergers & acquisitions (18226)
Metabolic disorders (944)
mRNA (197)
Multiple sclerosis (137)
NASH (7)
Neurodegenerative disease (336)
Neuropsychiatric disorders (54)
Neuroscience (2488)
NextGen: Class of 2026 (5050)
Non-profit (2026)
Now hiring (20)
Obesity (308)
Opinion (119)
Ovarian cancer (193)
Pain (215)
Pancreatic cancer (280)
Parkinson's disease (302)
Partnered (26)
Patents (605)
Patient recruitment (702)
Peanut (61)
People (53228)
Pharmaceutical (40)
Pharmacy benefit managers (12)
Phase 1 (18981)
Phase 2 (25444)
Phase 3 (17200)
Pipeline (9527)
Policy (79)
Postmarket research (1729)
Preclinical (8187)
Press Release (69)
Prostate cancer (272)
Psychedelics (10)
Radiopharmaceuticals (319)
Rare diseases (783)
Real estate (4880)
Recruiting (25)
Regulatory (19580)
Reports (28)
Research institute (1583)
Resumes & cover letters (107)
Rett syndrome (48)
RNA editing (19)
RSV (66)
Schizophrenia (118)
Series A (282)
Series B (198)
Service/supplier (6)
Sickle cell disease (77)
Special edition (1)
Spinal muscular atrophy (106)
Sponsored (26)
Startups (3310)
State (2)
Stomach cancer (4)
Supply chain (80)
Tariffs (12)
The Weekly (25)
Vaccines (713)
Venture capital (68)
Weight loss (114)
Women's health (107)
Worklife (4)
Date
Today (62)
Last 7 days (309)
Last 30 days (2014)
Last 365 days (25123)
2026 (16455)
2025 (25199)
2024 (30104)
2023 (34735)
2022 (45177)
2021 (48663)
2020 (45650)
2019 (36326)
2018 (27258)
2017 (27220)
2016 (26234)
2015 (32734)
2014 (27768)
2013 (23737)
2012 (25695)
2011 (26032)
2010 (24910)
Location
Africa (451)
Alabama (88)
Alaska (6)
Arizona (363)
Arkansas (16)
Asia (33584)
Australia (5240)
California (13656)
Canada (3725)
China (1113)
Colorado (599)
Connecticut (536)
Delaware (302)
Europe (64040)
Florida (2062)
Georgia (443)
Hawaii (4)
Idaho (60)
Illinois (1031)
India (88)
Indiana (443)
Iowa (22)
Japan (586)
Kansas (127)
Kentucky (46)
Louisiana (42)
Maine (39)
Maryland (1522)
Massachusetts (9556)
Michigan (401)
Minnesota (752)
Mississippi (6)
Missouri (149)
Montana (31)
Nebraska (19)
Nevada (131)
New Hampshire (89)
New Jersey (3188)
New Mexico (27)
New York (3458)
North Carolina (1667)
North Dakota (10)
Northern California (6792)
Ohio (387)
Oklahoma (23)
Oregon (28)
Pennsylvania (2617)
Puerto Rico (26)
Rhode Island (50)
South America (727)
South Carolina (90)
South Dakota (1)
Southern California (5616)
Tennessee (199)
Texas (2250)
United States (46803)
Utah (425)
Vermont (2)
Virginia (238)
Washington D.C. (52)
Washington State (1102)
West Virginia (3)
Wisconsin (149)
Wyoming (2)
636,756 Results for "biorem technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biorem Reports Second Quarter 2025 Results
August 25, 2025
·
3 min read
Press Releases
Biorem Reports Record Order Backlog, - $11.3 Million of Revenues in the Quarter and Quarterly EPS of $0.07
November 18, 2025
·
3 min read
Press Releases
BIOREM Reports First Quarter Financial Results and Record $68 Million Order Backlog
May 28, 2025
·
3 min read
Business
Biorem Reports Record 2022 Financial Results
BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three and twelve-month periods ended December 31, 2022.
April 5, 2023
·
4 min read
Press Releases
Biorem Reports Record Revenues and Earnings before tax for 2024 and Again Reports Record Order Backlog
April 16, 2025
·
4 min read
Business
Biorem Reports Second Quarter Results and Record Order Backlog
BIOREM Inc. today announced its results for the three and six-month periods ended June 30, 2023.
August 23, 2023
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Business
Biorem Reports First Quarter Financial Results - May 24, 2023
BIOREM Inc. today announced results for the three month period ended March 31, 2023.
May 24, 2023
·
3 min read
Deals
Biorem Announces Stock Option Grant - June 9, 2023
Biorem Inc. announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company.
June 9, 2023
·
1 min read
Press Releases
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
July 22, 2026
·
8 min read
1 of 63,676
Next
